Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID, 2989,"Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429.",lymphocyte quantity,,RS:0004632,SD-Fhem1+/-,male,0 days,3,,CMO:0000371,blood lymphocyte count to total leukocyte count ratio,,,,50.7,%,4.0415,7.0,MMO:0000179,automated blood analysis,,0.0,,,,,control condition,104887,control condition 2989,"Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429.",lymphocyte quantity,,RS:0004632,SD-Fhem1+/-,female,0 days,3,,CMO:0000371,blood lymphocyte count to total leukocyte count ratio,,,,57.8,%,4.5611,7.9,MMO:0000179,automated blood analysis,,0.0,,,,,control condition,104888,control condition